Advanced

An official American Thoracic Society workshop report : Stem cells and cell therapies in lung biology and diseases

Weiss, Daniel J.; Chambers, Daniel; Giangreco, Adam; Keating, Armand; Kotton, Darrell; Lelkes, Peter I.; Wagner, Darcy E. LU ; Prockop, Darwin J and , (2015) Stem Cells and Cell Therapies in Lung Biology and Lung Diseases In Annals of the American Thoracic Society 12(4). p.79-97
Abstract

The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases, " held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and... (More)

The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases, " held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to four previous biennial conferences held at the University of Vermont in 2005, 2007, 2009, and 2011. Each of those conferences, also sponsored by the National Institutes of Health, American Thoracic Society, and Respiratory Disease Foundations, has been important in helping guide research and funding priorities. The major conference recommendations are summarized at the end of the report and highlight both the significant progress and major challenges in these rapidly progressing fields.

(Less)
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
in
Annals of the American Thoracic Society
volume
12
issue
4
pages
79 - 97
publisher
American Thoracic Society
conference name
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
external identifiers
  • scopus:84928724209
ISSN
2325-6621
DOI
10.1513/AnnalsATS.201502-086ST
language
English
LU publication?
no
id
c14b7a7f-c983-4edd-8352-69a8fcde2697
date added to LUP
2017-08-15 15:02:34
date last changed
2017-10-01 05:38:35
@article{c14b7a7f-c983-4edd-8352-69a8fcde2697,
  abstract     = {<p>The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases, " held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to four previous biennial conferences held at the University of Vermont in 2005, 2007, 2009, and 2011. Each of those conferences, also sponsored by the National Institutes of Health, American Thoracic Society, and Respiratory Disease Foundations, has been important in helping guide research and funding priorities. The major conference recommendations are summarized at the end of the report and highlight both the significant progress and major challenges in these rapidly progressing fields.</p>},
  author       = {Weiss, Daniel J. and Chambers, Daniel and Giangreco, Adam and Keating, Armand and Kotton, Darrell and Lelkes, Peter I. and Wagner, Darcy E. and Prockop, Darwin J and , },
  issn         = {2325-6621},
  language     = {eng},
  month        = {04},
  number       = {4},
  pages        = {79--97},
  publisher    = {American Thoracic Society},
  series       = {Annals of the American Thoracic Society},
  title        = {An official American Thoracic Society workshop report : Stem cells and cell therapies in lung biology and diseases},
  url          = {http://dx.doi.org/10.1513/AnnalsATS.201502-086ST},
  volume       = {12},
  year         = {2015},
}